Literature DB >> 17951498

Glucagon-like peptide-1 and energy homeostasis.

Rémy Burcelin1, Patrice D Cani, Claude Knauf.   

Abstract

A growing body of evidence demonstrates the role of gut-derived hormones in the control of energy homeostasis. Among those intestinal signals, physiological and therapeutic interest has been drawn to glucagon-like peptide-1 (GLP-1). The main reasons are that this hormone 1) is secreted by epithelial intestinal L-cells in response to glucose and lipids, 2) enhances glucose-stimulated insulin secretion, 3) improves blood glucose profiles of type 2 diabetic patients by means of several actions on pancreatic hormone secretions, 4) reduces body weight and food intake, and 5) slows gastric emptying. Furthermore, recent evidence has suggested that the nervous system is a key player accounting for the beneficial role of GLP-1 on the control of energy homeostasis. Hence, the role of GLP-1 on the gut-to-brain axis is reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951498     DOI: 10.1093/jn/137.11.2534S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  11 in total

Review 1.  β-Arrestins: multifunctional signaling adaptors in type 2 diabetes.

Authors:  Xiaotao Feng; Wenjian Wang; Jibo Liu; Yi Liu
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 2.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

Review 3.  Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.

Authors:  A Zarrinpar; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2012-10-11       Impact factor: 8.171

Review 4.  Metabolic syndrome as a risk factor for neurological disorders.

Authors:  Akhlaq A Farooqui; Tahira Farooqui; Francesco Panza; Vincenza Frisardi
Journal:  Cell Mol Life Sci       Date:  2011-10-15       Impact factor: 9.261

Review 5.  Incretin hormones and the satiation signal.

Authors:  J J Holst
Journal:  Int J Obes (Lond)       Date:  2013-01-08       Impact factor: 5.095

6.  High β-Glucan Barley Supplementation Improves Glucose Tolerance by Increasing GLP-1 Secretion in Diet-Induced Obesity Mice.

Authors:  Sachina Suzuki; Seiichiro Aoe
Journal:  Nutrients       Date:  2021-02-06       Impact factor: 5.717

7.  High Hydrostatic Pressure Processing of Human Milk Increases Apelin and GLP-1 Contents to Modulate Gut Contraction and Glucose Metabolism in Mice Compared to Holder Pasteurization.

Authors:  Eve Wemelle; Lucie Marousez; Marie de Lamballerie; Claude Knauf; Jean Lesage
Journal:  Nutrients       Date:  2022-01-05       Impact factor: 5.717

8.  Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.

Authors:  Cendrine Cabou; Gérard Campistron; Nicolas Marsollier; Corinne Leloup; Celine Cruciani-Guglielmacci; Luc Pénicaud; Daniel J Drucker; Christophe Magnan; Rémy Burcelin
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

Review 9.  Is there any interplay between incretins and bile acids? What is the role of bariatric surgery?

Authors:  Alina Pârvu; Florinela Cătoi
Journal:  Clujul Med       Date:  2014-01-30

10.  Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine.

Authors:  Qian Zhang; Xinhua Xiao; Ming Li; Wenhui Li; Miao Yu; Huabing Zhang; Fan Ping; Zhixin Wang; Jia Zheng
Journal:  BMC Complement Altern Med       Date:  2014-06-09       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.